The geriatric syndrome of sarcopenia impacts allogeneic hematopoietic cell transplantation outcomes in older lymphoma patients

References

• Giralt SA. Hematopoietic cell transplantation for older adults. In: Handbook of Geriatric Oncology - Practical Guide to Caring for the Older Cancer Patient. New York (NY): Demos Medical; 2019. p. 241–254.
   Google Scholar
• D’Souza A, Fretham C. Current Uses and Outcomes of Hematopoietic Cell Transplantation (HCT): CIBMTR Summary Slides, 2018. Available from: CIBMTRhttp://www.cibmtr.org.
   Google Scholar
• Hahn T, McCarthy PL, Hassebroek A, et al. Significant improvement in survival after allogeneic hematopoietic cell transplantation during a period of significantly increased use, older recipient age, and use of unrelated donors. JCO. 2013;31(19):2437–2449.
   PubMed Web of Science ®Google Scholar
• Majhail NS, Chitphakdithai P, Logan B, et al. Significant improvement in survival after unrelated donor hematopoietic cell transplantation in the recent era. Biol Blood Marrow Transplant. 2015;21(1):142–150.
   PubMed Web of Science ®Google Scholar
• Artz A. Biologic vs physiologic age in the transplant candidate. Hematology. 2016;2016(1):99–105.
   PubMedGoogle Scholar
• Elsawy M, Sorror M. Up-to-date tools for risk assessment before allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2016;51(10):1283–1300.
   PubMed Web of Science ®Google Scholar
• McClune BL, Weisdorf DJ, Pedersen TL, et al. Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome. JCO . 2010;28(11):1878–1887.
   PubMed Web of Science ®Google Scholar
• Sorror ML, Sandmaier BM, Storer BE, et al. Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies. JAMA. 2011;306(17):1874–1883.
   PubMed Web of Science ®Google Scholar
• Rashidi A, Ebadi M, Colditz GA, et al. Outcomes of allogeneic stem cell transplantation in elderly patients with acute myeloid leukemia: a systematic review and meta-analysis. Biol Blood Marrow Transplant. 2016;22(4):651–657.
   PubMed Web of Science ®Google Scholar
• Inouye SK, Studenski S, Tinetti ME, et al. Geriatric syndromes: clinical, research, and policy implications of a core geriatric concept. J Am Geriatr Soc. 2007;55(5):780–791.
   PubMed Web of Science ®Google Scholar
• Kane RL, Shamliyan T, Talley K, et al. The association between geriatric syndromes and survival. J Am Geriatr Soc. 2012;60(5):896–904.
   PubMed Web of Science ®Google Scholar
• Abel GA, Klepin HD. Frailty and the management of hematologic malignancies. Blood. 2018;131(5):515–524.
   PubMed Web of Science ®Google Scholar
• Lin RJ, Hilden PD, Elko TA, et al. Burden and impact of multifactorial geriatric syndromes in allogeneic hematopoietic cell transplantation for older adults. Blood Adv. 2019;3(1):12–20.
   PubMed Web of Science ®Google Scholar
• Mohile SG, Dale W, Somerfield MR, et al. Practical assessment and management of vulnerabilities in older patients receiving chemotherapy: ASCO Guideline for Geriatric Oncology. JCO. 2018;36(22):2326–2347.
   PubMed Web of Science ®Google Scholar
• Muffly LS, Kocherginsky M, Stock W, et al. Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipients. Haematologica. 2014;99(8):1373–1379.
   PubMed Web of Science ®Google Scholar
• Deschler B, Ihorst G, Schnitzler S, et al. Geriatric assessment and quality of life in older patients considered for allogeneic hematopoietic cell transplantation: a prospective risk factor and serial assessment analysis. Bone Marrow Transplant. 2018;53(5):565–575.
   PubMed Web of Science ®Google Scholar
• Lin RJ, Elko TA, Devlin S, et al. Impact of geriatric vulnerabilities on allogeneic hematopoietic cell transplantation outcomes in older patients with hematologic malignancies. Bone Marrow Transplant. 2020;55(1):157–164.
   Google Scholar
• Huang L-W, Sheng Y, Andreadis C, et al. Functional status as measured by geriatric assessment predicts inferior survival in older allogeneic hematopoietic cell transplant recipients. Biol Blood Marrow Transplant. 2020;26(1):189–196.
   Web of Science ®Google Scholar
• Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet. 2019;393(10191):2636–2646.
   PubMed Web of Science ®Google Scholar
• Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31.
   Web of Science ®Google Scholar
• Yang M, Shen Y, Tan L, et al. Prognostic value of sarcopenia in lung cancer: A systematic review and meta-analysis. Chest. 2019;156(1):101–111.
   PubMed Web of Science ®Google Scholar
• Caan BJ, Feliciano EM, Prado CM, et al. Association of muscle and adiposity measured by computed tomography with survival in patients with nonmetastatic breast cancer. JAMA Oncol. 2018;4(6):798.
   PubMed Web of Science ®Google Scholar
• Shachar S, Williams GR, Muss HB, et al. Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review. Eur J Cancer. 2016; 57:58–67.
   PubMed Web of Science ®Google Scholar
• Caram MV, Bellile EL, Englesbe MJ, et al. Sarcopenia is associated with autologous transplant-related outcomes in patients with lymphoma. Leukemia Lymphoma. 2015;56(10):2855–2862.
   PubMed Web of Science ®Google Scholar
• Armenian SH, Xiao M, Teh J, et al. Impact of sarcopenia on adverse outcomes after allogeneic hematopoietic cell transplantation. J Natl Cancer I. 2019; 111(8):837–844.
   Google Scholar
• DeFilipp Z, Troschel FM, Qualls DA, et al. Evolution of body composition following autologous and allogeneic hematopoietic cell transplantation: incidence of sarcopenia and association with clinical outcomes. Biol Blood Marrow Transplant. 2018;24(8):1741–1747.
   PubMed Web of Science ®Google Scholar
• Fenske TS, Hamadani M, Cohen JB, et al. Allogeneic hematopoietic cell transplantation as curative therapy for patients with non-Hodgkin lymphoma: increasingly successful application to older patients. Biol Blood Marrow Transplant. 2016;22(9):1543–1551.
   PubMed Web of Science ®Google Scholar
• Shah NN, Ahn KW, Litovich C, et al. Outcomes of Medicare-age eligible NHL patients receiving RIC allogeneic transplantation: a CIBMTR analysis. Blood Adv. 2018;2(8):933–940.
   PubMed Web of Science ®Google Scholar
• Hunter BD, Chen Y-B, Jacobson CA. Allogeneic stem cell transplantation and chimeric antigen receptor (CAR) T-cell therapy for the treatment of non-Hodgkin lymphoma. Hematol/Oncol Clin North Am. 2019;33(4):687–705.
   PubMed Web of Science ®Google Scholar
• Martin L, Birdsell L, MacDonald N, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. JCO. 2013;31(12):1539–1547.
   PubMed Web of Science ®Google Scholar
• Mourtzakis M, Prado C, Lieffers JR, et al. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab. 2008;33(5):997–1006.
   PubMed Web of Science ®Google Scholar
• The Panel B. American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2015; 63:2227–2246.
   PubMed Web of Science ®Google Scholar
• Sorror ML. How I assess comorbidities before hematopoietic cell transplantation. Blood. 2013;121(15):2854–2863.
   PubMed Web of Science ®Google Scholar
• Armand P, Kim HT, Logan BR, et al. Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation. Blood. 2014;123(23):3664–3671.
   PubMed Web of Science ®Google Scholar
• Otten L, Stobäus N, Franz K, et al. Impact of sarcopenia on 1-year mortality in older patients with cancer. Age Ageing. 2019;48(3):413–418.
   PubMed Web of Science ®Google Scholar
• Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12(5):489–495.
   PubMed Web of Science ®Google Scholar
• van Vugt J, Levolger S, Gharbharan A, et al. A comparative study of software programmes for cross‐sectional skeletal muscle and adipose tissue measurements on abdominal computed tomography scans of rectal cancer patients. J Cachexia Sarcopenia Muscle. 2017;8(2):285–297.
   PubMed Web of Science ®Google Scholar
• Perthen JE, Ali T, McCulloch D, et al. Intra- and interobserver variability in skeletal muscle measurements using computed tomography images. Eur J Radiol. 2018; 109:142–146.
   PubMed Web of Science ®Google Scholar
• Ryan AM, Prado CM, Sullivan ES, et al. Impact of weight loss and sarcopenia on response to chemotherapy, quality of life and survival. Nutrition. 2019; 67–68:110539.
   PubMed Web of Science ®Google Scholar
• Mitnitski AB, Mogilner AJ, Rockwood K. Accumulation of deficits as a proxy measure of aging. SciencetificWorldJournal. 2001;1:323–336.
   PubMedGoogle Scholar
• Tanaka S, Imataki O, Kitaoka A, et al. Clinical impact of sarcopenia and relevance of nutritional intake in patients before and after allogeneic hematopoietic stem cell transplantation. J Cancer Res Clin Oncol. 2017;143(6):1083–1092.
   PubMed Web of Science ®Google Scholar
• Skaarud K, Veierød M, Lergenmuller S, et al. Body weight, body composition and survival after 1 year: follow-up of a nutritional intervention trial in allo-HSCT recipients. Bone Marrow Transpl. 2019;54(12):2102–2109.
   PubMed Web of Science ®Google Scholar